Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

México 14000

0 studies enrolling now · 4 studies all time

What they study most

AML Arising From Myelodysplastic Syndrome (MDS), COVID-19 Pneumonia, Leukemia, Myeloid, Acute, Newly Diagnosed Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Untreated AML

Studies at this site

• A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma — Running, not enrolling
• Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia — Completed
• A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia — Completed